Imaging-Robotics Integration Shows Promise for Earlier Lung Cancer Diagnosis
The solution integrates robotic bronchoscopy with mobile cone beam CT imaging, reportedly increasing Stage 1A diagnoses by 291% in early use.
The solution integrates robotic bronchoscopy with mobile cone beam CT imaging, reportedly increasing Stage 1A diagnoses by 291% in early use.
Siemens Healthcare announced that the Food and Drug Administration has cleared its Somatom computed tomography (CT) systems for low-dose lung cancer screening. According to the company, the Somatom Scope 16-slice CT system and Somatom Force will make low-dose lung cancer screening more broadly available to customers.
The solution integrates robotic bronchoscopy with mobile cone beam CT imaging, reportedly increasing Stage 1A diagnoses by 291% in early use.